Consequences of Reprogrammed CD8+ T-Cell Therapy for Lewis Lung Carcinoma Cells and Neovasculogenesis in C57BL/6 Mice.

MLA

Skurikhin, E. G., et al. “Consequences of Reprogrammed CD8+ T-Cell Therapy for Lewis Lung Carcinoma Cells and Neovasculogenesis in C57BL/6 Mice.” Bulletin of Experimental Biology & Medicine, vol. 178, no. 2, Dec. 2024, pp. 244–49. EBSCOhost, https://doi.org/10.1007/s10517-025-06315-z.

APA

Skurikhin, E. G., Ermakova, N. N., Zhukova, M. A., Pan, E. S., Zharkikh, I. L., Pan, V. Y., Kubatiev, A. A., Morozov, S. G., Skurikhina, V. E., Minakova, M. Y., Pershina, O. V., & Dygai, A. M. (2024). Consequences of Reprogrammed CD8+ T-Cell Therapy for Lewis Lung Carcinoma Cells and Neovasculogenesis in C57BL/6 Mice. Bulletin of Experimental Biology & Medicine, 178(2), 244–249. https://doi.org/10.1007/s10517-025-06315-z

Chicago

Skurikhin, E. G., N. N. Ermakova, M. A. Zhukova, E. S. Pan, I. L. Zharkikh, V. Yu. Pan, A. A. Kubatiev, et al. 2024. “Consequences of Reprogrammed CD8+ T-Cell Therapy for Lewis Lung Carcinoma Cells and Neovasculogenesis in C57BL/6 Mice.” Bulletin of Experimental Biology & Medicine 178 (2): 244–49. doi:10.1007/s10517-025-06315-z.